Published 2010 | Version v1
Journal article

Prediction of the response to the neo-adjuvant chemotherapy of breast cancer after two therapies of cyclophosphamide/epirubicin (E.C.) by PET-CT 18F-F.D.G

  • 1. Hopital Saint-Louis, Service de medecine nucleaire, 75 - Paris (France)
  • 2. Hopital Saint-Louis, Service des maladies du sein, 75 - Paris (France)
  • 3. Hopital Saint-Louis, Service d'anatomie pathologique, 75 - Paris (France)

Description

Purpose: in order to make easy the communication between clinician doctors and nuclear doctors, we created a standardized application of sentinel node scintigraphy requirement in case of breast cancer. Conclusions: experience shows that the transfer of information through the intermediary of the specific order only takes a minute. The specific order facilitates communication between medical doctors for the patients profit, with a budget of minimum time. (N.C.)

Availability note (English)

Available from doi: <http://dx.doi.org/10.1016/j.mednuc.2010.02.004

Additional details

Additional titles

Original title (French)
Prediction de la reponse a la chimiotherapie neoadjuvante du cancer du sein apres deux cures de cyclophosphamide/epirubicine (EC) par TEP-TDM

Identifiers

Publishing Information

Journal Title
Medecine Nucleaire. Imagerie Fonctionnelle et Metabolique
Journal Volume
34
Journal Issue
no.5
Journal Page Range
p. 278-279
ISSN
0928-1258
CODEN
MNIMEX

Conference

Title
48. Colloquium of French nuclear medicine
Original Conference Title
48. Colloque de medecine nucleaire de langue francaise
Dates
8-11 May 2010
Place
Nice (France)